CVI Holdings’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

CVI Holdings’s Portfolio EVLO Stock Details EVLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-42,029	Closed	-$152K	–	377
2023 Q1	$152K	Sell	42,029 -31,550	-43%	-$487K	0.06%	144
2022 Q4	$2.37M	Sell	73,579 -11,104	-13%	-$440K	0.3%	117
2022 Q3	$3.54M	Sell	84,683 -18,057	-18%	-$826K	0.27%	126
2022 Q2	$4.34M	Buy	+102,740	New	+$4.76M	0.32%	99

Other funds holding EVLO

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CVI Holdings's EVLO Position: Q2 2023 in Review

CVI Holdings sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q2 2023, closing a stake of 42,029 shares — an estimated $152K sold.

CVI Holdings first reported a position in EVLO in Q2 2022 and held it in 4 quarters. The position peaked at $4.34M in Q2 2022. 25 funds tracked by Wall St. Rank hold EVLO as of Q2 2023.

CVI Holdings reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
CVI Holdings sold 42,029 Evelo Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $152K.
CVI Holdings first reported a position in Evelo Biosciences, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
CVI Holdings's Evelo Biosciences, Inc. Common Stock position peaked at $4.34M in Q2 2022.
25 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q2 2023.

Based on CVI Holdings's 13F filing for Q2 2023, filed 11 Aug 2023.